REGN7041
/ Regeneron
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 09, 2026
R7041-NIU-24123: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
(clinicaltrialsregister.eu)
- P1/2 | N=5 | Not yet recruiting | Sponsor: Regeneron Pharmaceuticals Inc.
New P1/2 trial • Ocular Inflammation • Ophthalmology • Uveitis
1 to 1
Of
1
Go to page
1